About Pacific GeneTech
Pacific GeneTech is a company based in Hong Kong (China) founded in 2009. Pacific GeneTech has raised $10 million across 1 funding round from investors including Arkansas.gov, Simmons Foods and WHIST. Pacific GeneTech offers products and services including Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine. Pacific GeneTech operates in a competitive market with competitors including Biological E, Insmed, Affinivax, Merck Animal Health and Altimmune, among others.
- Headquarter Hong Kong, China
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pacific Genetech Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 24, 2022
-
Investors
Arkansas.gov
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pacific GeneTech
Pacific GeneTech offers a comprehensive portfolio of products and services, including Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine.
Enables broad-spectrum protection for vaccines against pathogens
Supports administration of inactivated vaccines for enhanced efficacy
Targets Salmonella in poultry and livestock for disease prevention
Funding Insights of Pacific GeneTech
Pacific GeneTech has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pacific GeneTech
Pacific GeneTech has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Arkansas.gov, Simmons Foods and WHIST.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Simmons Foods is engaged in poultry and pet food production.
|
Locked | Locked | Locked | |
|
Access to government programs and development services is provided.
|
Locked | Locked | Locked | |
|
Women's health and empowerment services are provided in South Tyneside.
|
Locked | Locked | Locked |
Investor details for Pacific GeneTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pacific GeneTech
Investment portfolio details for Pacific GeneTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pacific GeneTech
Detailed financials for Pacific GeneTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pacific Genetech Comparisons
Peer comparison for Pacific GeneTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pacific GeneTech
Pacific GeneTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Insmed, Affinivax, Merck Animal Health and Altimmune, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of small molecule inhibitors for rare lung diseases
|
|
| Locked | Locked | Locked |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Vaccine technology is developed and supplied for livestock animals.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for treating multiple infectious diseases
|
Detailed competitors of Pacific GeneTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pacific Genetech
Complete news archive for Pacific GeneTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pacific GeneTech
Pacific GeneTech was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Pacific GeneTech is headquartered in Hong Kong, China.
Tim Collard is the current CEO of Pacific GeneTech.
Pacific GeneTech is a funded company, having raised a total of $10M across 1 funding round to date.
Pacific GeneTech was founded in 2009 in Hong Kong, China, within the biotechnology sector. Vaccines targeting viral, bacterial, and parasitic diseases in animals and humans are developed using microbial vectors via the Aegis Vaccine Platform for gene insertion. Operations focus on gene delivery systems, with a pipeline that includes PGT Hercules Adjuvant, a modified chitosan applied to multiple disease indications.
Pacific GeneTech's top competitors include Biological E, Insmed and Vaxart.
Pacific GeneTech offers Aegis Vaccine Platform, Hercules Adjuvant System, and Salmonella Vaccine.
Pacific GeneTech has 4 investors. Key investors include Arkansas.gov, Simmons Foods, WHIST, and PT Medion Ardhika Bhakti.